KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) EPS (Weighted Average and Diluted) (2016 - 2026)

Sabra Health Care REIT has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at $0.16 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 5.88% year-over-year to $0.16; the TTM value through Mar 2026 reached $0.63, up 5.0%, while the annual FY2025 figure was $0.64, 18.52% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.16 at Sabra Health Care REIT, up from $0.11 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.27 in Q2 2025 and troughed at -$0.37 in Q4 2022.
  • A 5-year average of $0.06 and a median of $0.1 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 540.0% in 2022 and later surged 375.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.37 in 2022, then soared by 118.92% to $0.07 in 2023, then surged by 185.71% to $0.2 in 2024, then plummeted by 45.0% to $0.11 in 2025, then skyrocketed by 45.45% to $0.16 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SBRA at $0.16 in Q1 2026, $0.11 in Q4 2025, and $0.09 in Q3 2025.